BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
Income statement
| Line | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B | $11.0B | $13.4B | $14.4B | $13.5B | $12.3B | $11.4B | $10.8B | $9.7B | $6.9B | $5.5B | $5.0B | $4.7B | $4.4B | $4.1B | $3.2B |
| Cost of revenue | $2.4B | $2.1B | $1.8B | $2.0B | $1.8B | $1.6B | $1.5B | $1.2B | $1.2B | $858M | $545M | $467M | $400M | $382M | $402M | $335M |
| Gross profit | $8.4B | $8.9B | $11.6B | $12.4B | $11.6B | $10.6B | $10.0B | $9.5B | $8.5B | $6.1B | $5.0B | $4.6B | $4.3B | $4.0B | $3.7B | $2.8B |
| R&D | $2.5B | $2.5B | $4.0B | $2.3B | $2.6B | $2.3B | $2.0B | $2.0B | $1.9B | $1.4B | $1.3B | $1.2B | $1.2B | $1.3B | $1.1B | $925M |
| SG&A | $2.7B | $2.7B | $2.5B | $2.4B | $2.1B | $1.9B | $1.9B | $2.1B | $2.2B | $1.7B | $1.3B | $1.1B | $1.0B | $911M | $925M | $776M |
| Other operating expenses | $704M | $856M | $594M | $725M | $1.0B | $1.1B | $899M | $507M | $434M | $403M | $503M | $581M | $787M | $506M | $485M | $355M |
| Operating income | $2.5B | $2.8B | $4.6B | $7.0B | $5.9B | $5.3B | $5.2B | $4.9B | $4.0B | $2.5B | $1.9B | $1.7B | $1.2B | $1.3B | $1.2B | $780M |
| Non-operating income | −$852M | −$1.1B | $497M | $83M | $11M | −$217M | −$219M | −$124M | −$26M | −$35M | −$744K | −$13M | −$19M | $37M | −$58M | $72M |
| Pretax income | $1.6B | $1.7B | $5.0B | $7.1B | $5.9B | $5.1B | $4.9B | $4.8B | $3.9B | $2.5B | $1.9B | $1.7B | $1.2B | $1.3B | $1.2B | $852M |
| Taxes | $176M | $189M | $1.0B | $1.2B | $1.5B | $2.6B | $1.2B | $1.2B | $1.0B | $618M | $475M | $477M | $225M | $363M | $373M | $214M |
| Net income | $1.4B | $1.6B | $4.0B | $5.9B | $4.4B | $2.5B | $3.7B | $3.5B | $2.9B | $1.9B | $1.4B | $1.2B | $1.0B | $970M | $783M | $638M |
| Diluted EPS | $9.77 | $10.40 | $24.80 | $31.42 | $21.58 | $11.92 | $16.93 | $15.34 | $12.37 | $7.81 | $5.76 | $5.04 | $3.94 | $3.35 | $2.65 | $1.99 |
| Diluted shares | — | 149.6M | 161.3M | 187.4M | 205.3M | 213.0M | 218.8M | 231.2M | 237.2M | 238.3M | 239.7M | 245.0M | 254.9M | 289.5M | 295.0M | 320.2M |
| Revenue growth | — | −18.3% | −6.5% | +6.9% | +9.6% | +7.2% | +6.4% | +10.9% | +40.0% | +25.7% | +9.3% | +7.0% | +7.7% | +6.8% | +29.2% | — |
| Gross margin | 78.0% | 80.8% | 86.6% | 86.4% | 86.5% | 86.7% | 87.1% | 88.5% | 87.9% | 87.6% | 90.1% | 90.8% | 91.5% | 91.3% | 90.2% | 89.4% |
| Operating margin | 22.9% | 25.9% | 33.8% | 49.0% | 43.8% | 43.6% | 45.0% | 45.4% | 40.9% | 36.3% | 33.6% | 34.2% | 26.5% | 29.6% | 29.6% | 24.6% |
| Net margin | 13.4% | 14.2% | 29.8% | 41.0% | 32.9% | 20.7% | 32.3% | 33.0% | 30.2% | 26.9% | 25.0% | 24.5% | 21.3% | 22.2% | 19.1% | 20.1% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.